James M. Koeller
About
In The Last Decade
James M. Koeller
11 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Surgery 832
- Physiology 371
- Oncology 251
- Pediatrics, Perinatology and Child Health 140
- Anesthesiology and Pain Medicine 128
Countries citing papers authored by James M. Koeller
This map shows the geographic impact of James M. Koeller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Koeller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Koeller more than expected).
Fields of papers citing papers by James M. Koeller
This network shows the impact of papers produced by James M. Koeller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Koeller. The network helps show where James M. Koeller may publish in the future.
Co-authorship network of co-authors of James M. Koeller
This figure shows the co-authorship network connecting the top 25 collaborators of James M. Koeller. A scholar is included among the top collaborators of James M. Koeller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Koeller. James M. Koeller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006 breakdown → | 516 |
| 4 | 3 | |
| 5 | 49 | |
| 6 | 8 | |
| 7 | Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines breakdown → | 483 |
| 8 | Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study. | 7 |
| 9 | A phase I clinical and pharmacokinetic trial of hepsulfam. | 11 |
| 10 | Phase II trial of recombinant beta interferon in advanced colorectal cancer. | 12 |
| 11 | Doxorubicin and interferon: rationale and clinical experience. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.